Hydroxyzine Pamoate — $0 on Listed Strengths

About Hydroxyzine Pamoate

Hydroxyzine pamoate is a versatile medication often prescribed to help manage anxiety, relieve itching from allergic reactions, and even induce sedation before medical procedures. At TheDrugClub, we believe essential medications like this should be affordable and accessible. ### What is Hydroxyzine Pamoate and What Does it Treat? Hydroxyzine pamoate is a widely used antihistamine with sedative properties. It's primarily prescribed for a few key conditions:

• Anxiety Management: It effectively helps reduce anxiety and tension, making it a common choice for short-term anxiety relief. * Allergy Relief: As an antihistamine, it's excellent at alleviating itching caused by allergic skin conditions like hives (urticaria), eczema, and contact dermatitis. It can also help with general allergy symptoms. * Sedation: Due to its calming effects, it's sometimes used as a sedative before and after general anesthesia, or for individuals needing help with sleep in specific situations. ### How Does Hydroxyzine Pamoate Work? Hydroxyzine pamoate works by blocking the action of histamine, a natural substance in the body that causes allergy symptoms. By blocking histamine

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Hydroxyzine Pamoate is approved for (FDA label)

For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus. As a sedative when used as premedication and following general anesthesia, hydroxyzine may potentiate meperidine (Demerol ® ) and barbiturates, so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. Atropine and other belladonna alkaloids are not affected by the drug. Hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent.

Source: Read the full FDA label on DailyMed. Label effective date: August 5, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Hydroxyzine Pamoate (FDA label)

Side effects reported with the administration of hydroxyzine pamoate are usually mild and transitory in nature. Skin and Appendages Oral hydroxyzine hydrochloride is associated with Acute Generalized Exanthematous Pustulosis (AGEP) and fixed drug eruptions in post-marketing reports. Anticholinergic Dry mouth. Central Nervous System Drowsiness is usually transitory and may disappear in a few days of continued therapy or upon reduction of the dose. Involuntary motor activity, including rare instances of tremor and convulsions, has been reported, usually with doses considerably higher than those recommended. Clinically significant respiratory depression has not been reported at recommended doses. Cardiac System QT prolongation, Torsade de Pointes.

Source: FDA prescribing information (DailyMed). Set ID: 0c9101ee-0746-4833-83cf-d0d09e52c0a9. SPL document ID: 584f47c7-d3b9-2060-e063-6294a90a4d3a. Label effective date: August 5, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Hydroxyzine Pamoate (FDA label)

Hydroxyzine, when administered to the pregnant mouse, rat, and rabbit, induced fetal abnormalities in the rat and mouse at doses substantially above the human therapeutic range. Clinical data in human beings are inadequate to establish safety in early pregnancy. Until such data are available, hydroxyzine is contraindicated in early pregnancy. Hydroxyzine is contraindicated in patients with a prolonged QT interval. Hydroxyzine pamoate is contraindicated for patients who have shown a previous hypersensitivity to any component of this medication. Hydroxyzine is contraindicated in patients with known hypersensitivity to hydroxyzine products, and in patients with known hypersensitivity to cetirizine hydrochloride or levocetirizine hydrochloride.

Source: FDA prescribing information (DailyMed). Set ID: 0c9101ee-0746-4833-83cf-d0d09e52c0a9. SPL document ID: 584f47c7-d3b9-2060-e063-6294a90a4d3a. Label effective date: August 5, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.